These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 21392036)

  • 1. Allergic contact dermatitis caused by an ethinylestradiol-norelgestromin transdermal therapeutic system.
    Alfaya T; Mur Gimeno P; Iglesias AM; Ventura P
    Contact Dermatitis; 2011 Apr; 64(4):242-4. PubMed ID: 21392036
    [No Abstract]   [Full Text] [Related]  

  • 2. Allergic contact dermatitis due to transdermal contraception patch.
    Stricker T; Sennhauser FH
    J Pediatr; 2006 Jun; 148(6):845. PubMed ID: 16769403
    [No Abstract]   [Full Text] [Related]  

  • 3. A clinical study of transdermal contraceptive patch in Thai adolescence women.
    Piyasirisilp R; Taneepanichskul S
    J Med Assoc Thai; 2008 Feb; 91(2):137-41. PubMed ID: 18389975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ethinylestradiol + norelgestromin: new preparation. Transdermal contraception: no tangible progress.
    Prescrire Int; 2004 Aug; 13(72):123-6. PubMed ID: 15532134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contact dermatitis from estradiol in a transdermal therapeutic system.
    Panhans-Gross A; Gall H; Dziuk M; Peter RU
    Contact Dermatitis; 2000 Dec; 43(6):368-9. PubMed ID: 11140397
    [No Abstract]   [Full Text] [Related]  

  • 6. Allergic contact dermatitis from transdermal estradiol and systemic contact dermatitis from oral estradiol. A case report.
    Corazza M; Mantovani L; Montanari A; Virgili A
    J Reprod Med; 2002 Jun; 47(6):507-9. PubMed ID: 12092023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allergic contact dermatitis caused by 2-ethylhexyl acrylate in a rivastigmine transdermal therapeutic system.
    Navarro-Triviño FJ; Ruiz-Villaverde R
    Contact Dermatitis; 2020 Aug; 83(2):143-145. PubMed ID: 32270504
    [No Abstract]   [Full Text] [Related]  

  • 8. Contact dermatitis from nitroglycerin in a transdermal therapeutic system.
    Roche Gamón E; De la Cuadra Oyanguren J; Pérez Ferriols A; Fortea Baixauli JM
    Acta Derm Venereol; 2006; 86(6):544-5. PubMed ID: 17106605
    [No Abstract]   [Full Text] [Related]  

  • 9. Contact dermatitis due to transdermal therapeutic systems: a clinical update.
    Romita P; Foti C; Calogiuri G; Cantore S; Ballini A; Dipalma G; Inchingolo F
    Acta Biomed; 2018 Oct; 90(1):5-10. PubMed ID: 30889148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.
    Jick S; Kaye JA; Li L; Jick H
    Contraception; 2007 Jul; 76(1):4-7. PubMed ID: 17586129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isobornyl acrylate contained in the insulin patch pump OmniPod as the cause of severe allergic contact dermatitis.
    Oppel E; Högg C; Summer B; Ruëff F; Reichl FX; Kamann S
    Contact Dermatitis; 2018 Sep; 79(3):178-180. PubMed ID: 29761499
    [No Abstract]   [Full Text] [Related]  

  • 12. [Hypersensitivity reactions to excipients in patches].
    Olthoff MV; Kunkeler ACM; van Hunsel FPAM; Beekwilder JMA; Borgsteede SD
    Ned Tijdschr Geneeskd; 2019 Sep; 163():. PubMed ID: 31556491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allergic contact dermatitis caused by benzophenone-4 in a printer.
    Caruana DM; McPherson T; Cooper S
    Contact Dermatitis; 2011 Mar; 64(3):183-4. PubMed ID: 21272034
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of the contraceptive patch and the vaginal ring on bone metabolism and bone mineral density: a prospective, controlled, randomized study.
    Massaro M; Di Carlo C; Gargano V; Formisano C; Bifulco G; Nappi C
    Contraception; 2010 Mar; 81(3):209-14. PubMed ID: 20159176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allergic contact dermatitis caused by glycyrrhetinic acid and castor oil.
    Sasseville D; Desjardins M; Almutawa F
    Contact Dermatitis; 2011 Mar; 64(3):168-9. PubMed ID: 21272025
    [No Abstract]   [Full Text] [Related]  

  • 16. Allergic contact dermatitis to testosterone and estrogen in transdermal therapeutic systems.
    Ta V; Chin WK; White AA
    Dermatitis; 2014; 25(5):279. PubMed ID: 25207692
    [No Abstract]   [Full Text] [Related]  

  • 17. Extended use of transdermal norelgestromin/ethinyl estradiol: a randomized trial.
    Stewart FH; Kaunitz AM; Laguardia KD; Karvois DL; Fisher AC; Friedman AJ
    Obstet Gynecol; 2005 Jun; 105(6):1389-96. PubMed ID: 15932834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patch testing in allergic contact dermatitis: is it useful to perform the cosmetic series in addition to the European standard series?
    Ada S; Seçkin D
    J Eur Acad Dermatol Venereol; 2010 Oct; 24(10):1192-6. PubMed ID: 20236197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An unusual case of contact dermatitis caused by wooden bracelets.
    Gómez-Muga S; Ratón-Nieto JA; Ocerin I
    Contact Dermatitis; 2009 Dec; 61(6):351-2. PubMed ID: 20059497
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacokinetics and pharmacodynamics of a transdermal contraceptive patch and an oral contraceptive.
    Devineni D; Skee D; Vaccaro N; Massarella J; Janssens L; LaGuardia KD; Leung AT
    J Clin Pharmacol; 2007 Apr; 47(4):497-509. PubMed ID: 17389559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.